Yuichiro Kikawa

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Metastatic Breast Cancer

Clinical Evaluation

Psychometric Properties

Top Venues

Breast cancer (Tokyo, Japan)

Japanese journal of clinical oncology

Breast cancer : basic and clinical research

This page only lists publications with an associated author ORCID identifier.

Publications

Yosuke Aoyama, Eri Hoshino, Akihiko Shimomura, Chikako Shimizu, Tomoko Taniyama, Manami Tada, Nao Yoshida, Hitomi Sato, Kiyomi Nonogaki, Kazumasa Yamamoto, Taro Yamanaka, Rika Kizawa, Takeshi Yamaguchi, Kiyo Tanaka, Yoko Kobayashi, Nobuko Tamura, Yuko Tanabe, Yuji Miura, Yuichiro Kikawa, Juhee Cho, Hidetaka Kawabata
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale. Breast cancer (Tokyo, Japan) (2023)
Hiroto Ishiki, Yuichiro Kikawa, Mitsumi Terada, Junki Mizusawa, Michitaka Honda, Tsuguo Iwatani, Tomonori Mizutani, Keita Mori, Naoki Nakamura, Tempei Miyaji, Takuhiro Yamaguchi, Masahiko Ando, Kenichi Nakamura, Haruhiko Fukuda, Naomi Kiyota, null null
Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy. Japanese journal of clinical oncology 53 (3) (2023)
Hiroto Ishiki, Yuichiro Kikawa, Mitsumi Terada, Junki Mizusawa, Michitaka Honda, Tsuguo Iwatani, Tomonori Mizutani, Keita Mori, Naoki Nakamura, Tempei Miyaji, Takuhiro Yamaguchi, Masahiko Ando, Kenichi Nakamura, Haruhiko Fukuda, Naomi Kiyota, null null
Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy. Japanese journal of clinical oncology (2023)
Yuichiro Kikawa, Yasuhiro Hagiwara, Tomomi Fujisawa, Kazuhiro Araki, Takayuki Iwamoto, Takafumi Sangai, Tadahiko Shien, Shintaro Takao, Reiki Nishimura, Masato Takahashi, Tatsuya Toyama, Tomohiko Aihara, Hirofumi Mukai, Naruto Taira
Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy. PloS one 17 (11) (2022)
Yuichiro Kikawa, Takeshi Kotake, Shigeru Tsuyuki, Yookija Kang, Sachiko Takahara, Yuri Fujimoto, Hiroyasu Yamashiro, Hiroshi Yoshibayashi, Masahiro Takada, Rie Yasuoka, Katsuhiko Nakatsukasa, Kazuhiko Yamagami, Hirofumi Suwa, Toshitaka Okuno, Ichiro Nakayama, Tatsushi Kato, Nobuko Ogura, Yoshio Moriguchi, Hiroshi Ishiguro, Tatsuo Kagimura, Tetsuya Taguchi, Tomoharu Sugie, Masakazu Toi
Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study. Breast cancer (Tokyo, Japan) 29 (5) (2022)
Yuichiro Kikawa, Takeshi Kotake, Yukiko Kajiwara, Kazuki Hashimoto, Hiroyasu Yamashiro, Shoichiro Ohtani, Shintaro Takao, Masakazu Toi
Clinical Predictive Factors for the Efficacy of Everolimus in Patients With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer: A Multicenter Retrospective Cohort Study in Japan. Breast cancer : basic and clinical research 13 (2019)
Yuichiro Kikawa, Yukimasa Hatachi, Gerhard Rumpold, Mariko Tokiwa, Sayaka Takebe, Takatsugu Ogata, Hironaga Satake, Hironori Kato, Akihito Tsuji, Hisateru Yasui, Bernhard Holzner
Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study. Breast cancer (Tokyo, Japan) 26 (2) (2018)